EP3309248
METHODS FOR ENGINEERING T CELLS FOR IMMUNOTHERAPY BY USING RNA-GUIDED CAS NUCLEASE SYSTEM
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
1.4.2014EP published:
9.6.2021EP application number:
17183472.4
EPO information:
European Patent Register
Max expiry date:
31.3.2034
Title:
METHODS FOR ENGINEERING T CELLS FOR IMMUNOTHERAPY BY USING RNA-GUIDED CAS NUCLEASE SYSTEM
Timeline
Today
1.4.2014EP application
9.6.2021EP Publication
Owner
Name:
CellectisAddress:
8 rue de la Croix Jarry, 75013 Paris, FR
Inventor
Name:
DUCHATEAU, PhilippeAddress:
91210 Draveil, FR
Name:
CHOULIKA, AndréAddress:
75015 Paris, FR
Name:
POIROT, LaurentAddress:
75020 Paris, FR
Priority
Number:
201370297Date:
29.5.2013Country:
DK
Number:
201361888259 PDate:
8.10.2013Country:
US
Number:
201361907858 PDate:
22.11.2013Country:
US
Number:
201361907874 PDate:
22.11.2013Country:
US
Number:
201370771Date:
13.12.2013Country:
DK
Number:
PCT/EP2014/051458Date:
24.1.2014Country:
WO
Classification
Categories:
C12N 9/22, C12N 15/63, C12N 5/0783, A61P 35/00